ESR1 and breast cancer: In particular, the seven TCGA primary breast cancer samples carrying ESR1 mutation are all deemed as MFP tumors, highlighting ESR1 mutation is a remarkable feature that can provide early warning signal of high metastatic risk in the patients with primary tumors, but their metastatic lesions are not detectable yet.